-
-
-
-
-
-
-
Bristol Myers Squibb to acquire Orbital Therapeutics for $1.5 billion
-
-
-
-
-
-
-
2seventy bio (TSVT) Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
-
-
-
-
-
-
-
Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: 'We believe it should bode moderately positively for ZLAB shares'
-
-
-
-
-
-
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel
-
-
-
-
-
-
-
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
-
-
-
-
-
-
-
Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Issues $13B of Notes to Fund Acquisitions
-
1,158,068 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

